CASI Pharmaceuticals
CASI
CASI
25 hedge funds and large institutions have $3.33M invested in CASI Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$392K | |
2 | +$284K | |
3 | +$39K | |
4 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$21K |
5 |
Northern Trust
Chicago,
Illinois
|
+$19.5K |
Top Sellers
1 | -$78K | |
2 | -$31K | |
3 | -$25.2K | |
4 |
WJA
Williams Jones & Associates
New York
|
-$20K |
5 |
Renaissance Technologies
New York
|
-$17.1K |